glp-1 news oct 9 2025 The next phase of the obesity drug race GLP-1 Pipeline Update: May 2025

Why a genetic baseline changes the dose conversation Population-average titration works for most patients, but a meaningful subset under-respond or over-respond to GLP-1 monotherapy in ways predicted by their genetics

Today, there are GLP-1 drugs made for diabetic patients (e.g., Ozempic and Mounjaro) and GLP-1s intended for weight loss patients (e.g., Wegovy and Zepbound)

This comprehensive approach helps maximize results while minimizing risks associated with self-guided therapy

You have to really resist the big brown eye treatment and that can be really hard in our busy lives today. Appetite suppressants may help stop the kind of begging that most pet owners are familiar with, but they come with one major drawback: that a pets appetite is often an important marker of their health

These are not optional supplements

Due to these reasons, manufacturers are charging higher prices